Thymoma in Myasthenia Gravis: From Diagnosis to Treatment
Author Information
Author(s): Romi Fredrik
Primary Institution: Haukeland University Hospital
Hypothesis
The presence of titin and RyR antibodies in an MG patient younger than 60 years strongly suggests a thymoma.
Conclusion
Thymoma should be surgically removed, and pre-surgery treatments like plasmapheresis or iv-IgG may be beneficial.
Supporting Evidence
- 50% of thymoma patients develop myasthenia gravis (MG).
- 95% of MG patients with thymoma have titin and RyR antibodies.
- Thymoma MG accounts for around 15% of all MG cases.
- Thymoma MG tends to be more severe than early-onset nonthymoma MG.
Takeaway
If someone has a type of cancer called thymoma and a disease that makes their muscles weak, doctors can help by removing the thymoma and giving special treatments.
Methodology
The study reviews the relationship between thymoma and myasthenia gravis, discussing diagnosis, treatment options, and antibody associations.
Participant Demographics
Thymoma MG is equally frequent in males and females and occurs at any age with a peak onset around 50 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website